Rx IP Update - December 2017

Published date20 December 2017
Law FirmSmart & Biggar
AuthorKevin Siu,Urszula Wojtyra,Katie Lee,Brandon Heard,Andrew Mandlsohn
Subject MatterMedical Devices,Patents,Medical Marijuana,Tortious Interference,Appeals,Disclosure Requirements,Dismissals,Financial Statements,Prescription Drugs,Biosimilars,Reversal,Controlled Substances,Drug Approvals,Canada,Amended Regulation,Leave to Amend,Health Care Providers,Apotex,New Guidance,Supreme Court of Canada,Pharmaceutical Industry,Health Canada,Constitutional Challenges,Patented Medicines,PMNOC Regulations,Patented Medicine Prices Review Board (PMPRB),Public Consultations

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT